Incyte announces validation by EMA of its MAA for pemigatinib in patients with cholangiocarcinoma Read more
Schrödinger and Bayer Collaborate to Co-Develop de novo Design Technology to Accelerate Drug Discovery Read more
Immunic Exercises its Option for the Exclusive Worldwide License to IMU-856 from Daiichi Sankyo Read more